Versant Ventures
Charles Warden currently serves as the Chief Executive Officer of Aquea Health, Inc., a position held since January 2020. In addition to this role, Charles has been a Managing Director at Versant Ventures since 2004, focusing on venture capital investments in entrepreneurial medical device companies while also serving as a board member. Previous experience includes being a Board Member at IANTECH, an ophthalmic surgery company dedicated to impactful solutions, from June 2016 to December 2018, and serving as a General Partner at SV Life Sciences from 1996 to 2004, where Charles led the firm's medical device investing activities. Charles Warden holds an MBA from Harvard Business School and has an educational background from Beloit College.
This person is not in the org chart
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.